浏览全部资源
扫码关注微信
Role of NLRP3 Inflammasome in Bone and Joint Diseases and Traditional Chinese Medicine Intervention： A Review
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 18, Pages: 241-250(2023)
- 作者机构：
1.甘肃中医药大学，兰州 730000
2.甘肃省中医院，兰州 730050
- 作者简介：
- 基金信息：
DOI：10.13422/j.cnki.syfjx.20230311
CLC： R284.2;R285;R289;R287;R22;R2-031;R33;R24Published：20 September 2023，
Published Online：01 February 2023，
Received：02 September 2022，
- 稿件说明：
扫 描 看 全 文
李向洲,邢涛,钱朝良等.NLRP3炎症小体在骨关节疾病中的作用及中医药干预进展[J].中国实验方剂学杂志,2023,29(18):241-250.
LI Xiangzhou,XING Tao,QIAN Chaoliang,et al.Role of NLRP3 Inflammasome in Bone and Joint Diseases and Traditional Chinese Medicine Intervention： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(18):241-250.
李向洲,邢涛,钱朝良等.NLRP3炎症小体在骨关节疾病中的作用及中医药干预进展[J].中国实验方剂学杂志,2023,29(18):241-250. DOI： 10.13422/j.cnki.syfjx.20230311.
LI Xiangzhou,XING Tao,QIAN Chaoliang,et al.Role of NLRP3 Inflammasome in Bone and Joint Diseases and Traditional Chinese Medicine Intervention： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(18):241-250. DOI： 10.13422/j.cnki.syfjx.20230311.
摘要
核苷酸结合寡聚化结构域样受体蛋白3（NLRP3）炎症小体是一种细胞内感应蛋白复合物，是先天免疫系统的重要参与者，可感知外来病原体和内源性危险信号。组织损伤后，NLRP3炎症小体的激活诱导促炎细胞因子白细胞介素（IL）-1
β
和IL-18的释放，同时促进消皮素D介导细胞焦亡。现有研究表明，NLRP3炎症小体通过诱发炎症级联反应、加速骨吸收和软骨破坏等形式在骨质疏松症、骨关节炎、类风湿性关节炎、痛风性关节炎等常见骨关节疾病发生及发展中发挥关键作用。因此，阻断NLRP3炎症小体信号通路可能成为治疗或预防骨关节疾病的有效策略。目前，研究人员在动物和临床研究中开发和测试了几种选择性靶向NLRP3炎症小体的药物，但由于不良反应明显、价格昂贵等原因导致进展不佳。中医药因其多靶点、多通路、多机制协同作用及价格低廉、不良反应低等独特优势在骨关节疾病的治疗中得到普遍认可。随着研究不断深入，中医药靶向干预NLRP3炎症小体治疗骨关节疾病受到广泛关注。该文通过分析整理近年来国内外相关文献，总结阐述NLRP3炎症小体在骨关节炎中的作用机制，并进一步对中医药靶向干预NLRP3炎症小体治疗骨关节疾病进展进行系统综述，以期为骨关节疾病的治疗提供新的思路及理论依据。
Abstract
Nucleotide binding oligomeric dome-like receptor protein 3 （NLRP3） inflammasome is an intracellular sensing protein complex， and it is an important player in the innate immune system， capable of sensing foreign pathogens and endogenous danger signals. After tissue injury， the activation of the NLRP3 inflammasome induces the release of the pro-inflammatory cytokines interleukin （IL）-1
β
and IL-18， while promoting gasdermin D-mediated pyroptosis. Existing studies have shown that NLRP3 inflammasome plays a key role in the occurrence and development of common bone and joint diseases such as osteoporosis， osteoarthritis， rheumatoid arthritis， and gouty arthritis by inducing inflammatory cascade reaction and accelerating bone resorption and cartilage destruction. Therefore， blocking the NLRP3 inflammasome signaling pathway may be an effective strategy to treat or prevent bone and joint diseases. Currently， researchers have developed and tested several drugs that selectively target the NLRP3 inflammasome in animal and clinical studies， but the progress has been poor due to obvious side effects and high prices. Traditional Chinese medicine （TCM） has been widely recognized in the treatment of bone and joint diseases due to its unique advantages of multi-target， multi-pathway， multi-mechanism synergism， low price， and low side effects. With the deepening of research， the targeted intervention of NLRP3 inflammasome by TCM in the treatment of bone and joint diseases has attracted wide attention. In this paper， the mechanism of NLRP3 inflammasome in osteoarthritis was summarized by analyzing relevant literature in China and abroad in recent years， and the progress of targeted intervention of NLRP3 inflammasome by TCM in the treatment of bone and joint diseases was systematically reviewed， so as to provide new ideas and theoretical basis for the treatment of bone and joint diseases.
关键词
核苷酸结合寡聚化结构域样受体蛋白3（NLRP3）炎症小体骨与关节疾病中医药机制
Keywords
nucleotide binding oligomeric dome-like receptor protein 3 （NLRP3）inflammasomebone and joint diseasestraditional Chinese medicinemechanism
references
WEAVERS H，MARTIN P.The cell biology of inflammation：From common traits to remarkable immunological adaptations［J］.J Cell Biol，2020，219（7）：e202004003.
MARTINON F，BURNS K，TSCHOPP J.The inflammasome：A molecular platform triggering activation of inflammatory caspases and processing of pro IL-beta［J］.Mol Cell，2002，10（2）：417-426.
MEZZAROMA E，ABBATE A，TOLDO S.NLRP3 inflammasome inhibitors in cardiovascular diseases［J］.Molecules，2021，26（4）：976-976.
GUAN Y，HAN F.Key mechanisms and potential targets of the NLRP3 inflammasome in neurodegenerative diseases［J］.Front Integr Neurosci，2020，14：37.
MURAKAMI T，NAKAMINAMI Y，TAKAHATA Y，et al.Activation and function of NLRP3 inflammasome in bone and joint-related diseases［J］.Int J Mol Sci，2022，23（10）：5365.
WANG Z，ZHANG S，XIAO Y，et al.NLRP3 inflammasome and inflammatory diseases［J］.Oxid Med Cell Longev，2020，2020：4063562.
PLACE D E，KANNEGANTI T D.Recent advances in inflammasome biology［J］.Curr Opin Immunol，2018，50：32-38.
AGOSTINI L，MARTINON F，BURNS K，et al.NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder［J］.Immunity，2004，20（3）：319-325.
ZHEN Y，ZHANG H.NLRP3 Inflammasome and inflammatory bowel disease［J］.Front Immunol，2019，10：276.
MANGAN M，OLHAVA E J，ROUSH W R，et al.Targeting the NLRP3 inflammasome in inflammatory diseases［J］.Nat Rev Drug Discov，2018，17（8）：588-606.
SEOANE P I，LEE B，HOYLE C，et al.The NLRP3-inflammasome as a sensor of organelle dysfunction［J］.J Cell Biol，2020，219（12）：e202006194.
XUE Y，ENOSI TUIPULOTU D，TAN W H，et al.Emerging activators and regulators of inflammasomes and pyroptosis［J］.Trends Immunol，2019，40（11）：1035-1052.
MUÑOZ-PLANILLO R，KUFFA P，MARTÍNEZ-COLÓN G，et al.K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter［J］.Immunity，2013，38（6）：1142-1153.
HAFNER-BRATKOVICL IVA，PELEGRINP P.Ion homeostasis and ion channels in NLRP3 inflammasome activation and regulation［J］.Curr Opin Immunol，2018，52（7）：8-17.
ABAIS J M，XIA M，ZHANG Y，et al.Redox regulation of NLRP3 inflammasomes：ROS as trigger or effector？［J］.Antioxid Redox Signal，2015，22（13）：1111-1129.
WEBER K，SCHILLING J D.Lysosomes integrate metabolic-inflammatory cross-talk in primary macrophage inflammasome activation［J］.J Biol Chem，2014，289（13）：9158-9171.
ZHOU R，YAZDI A S，MENU P，et al.A role for mitochondria in NLRP3 inflammasome activation［J］.Nature，2011，469（7329）：221-225.
ZHONG Z，LIANG S，SANCHEZ-LOPEZ E，et al.New mitochondrial DNA synthesis enables NLRP3 inflammasome activation［J］.Nature，2018，560（7717）：198-203.
SWANSON K V，DENG M，TING J P.The NLRP3 inflammasome：Molecular activation and regulation to therapeutics［J］.Nat Rev Immunol，2019，19（8）：477-489.
ZHOU Y，TONG Z，JIANG S，et al.The roles of endoplasmic reticulum in NLRP3 inflammasome activation［J］.Cells，2020，9（5）：1219.
KAYAGAKI N，WARMING S，LAMKANFI M，et al.Non-canonical inflammasome activation targets caspase-11［J］.Nature，2011，479（7371）：117-121.
KAYAGAKI N，STOWE I B，LEE B L，et al.Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling［J］.Nature，2015，526（7575）：666-671.
KARMAKAR M，MINNS M，GREENBERG E N，et al.N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis［J］.Nat Commun，2020，11（1）：2212.
YANG D，HE Y，MUÑOZ-PLANILLO R，et al.Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock［J］.Immunity，2015，43（5）：923-932.
PICCINI A，CARTA S，TASSI S，et al.ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way［J］.Proc Natl Acad Sci USA，2008，105（23）：8067-8072.
GAIDT M M，EBERT T S，CHAUHAN D，et al.Human monocytes engage an alternative inflammasome pathway［J］.Immunity，2016，44（4）：833-846.
HE Y，FRANCHI L，NÚÑEZ G.TLR agonists stimulate NLRP3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo［J］.J Immunol，2013，190（1）：334-339.
COMPSTON J E，MCCLUNG M R，LESLIE W D.Osteoporosis［J］.Lancet，2019，393（10169）：364-376.
PIETSCHMANN P，MECHTCHERIAKOVA D，MESHCHERYAKOVA A，et al.Immunology of osteoporosis： A mini-review［J］.Gerontology，2016，62（2）：128-137.
CLINE-SMITH A，AXELBAUM A，SHASHKOVA E，et al.Ovariectomy activates chronic low-grade inflammation mediated by memory T Cells， which promotes osteoporosis in mice［J］.J Bone Miner Res，2020，35（6）：1174-1187.
RUSCITTI P，CIPRIANI P，CARUBBI F，et al.The role of IL-1β in the bone loss during rheumatic diseases［J］.Mediators Inflamm，2015，2015：782382.
MAO C Y，WANG Y G，ZHANG X，et al.Double-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB，MAPK and BMP/Smad signaling pathways［J］.Cell Death Dis，2016，7（7）：e2296.
HUANG R L，YUAN Y，TU J，et al.Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation［J］.Cell Death Dis，2014，5（4）：e1187.
KE D，FU X，XUE Y，et al.IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro［J］.Biochem Biophys Res Commun，2018，497（3）：890-896.
MANSOORI MN，SHUKLA P，KAKAJI M，et al.IL-18BP is decreased in osteoporotic women：Prevents inflammasome mediated IL-18 activation and reduces Th17 differentiation［J］.Sci Rep，2016，6（1）：33680.
BONAR S L，BRYDGES S D，MUELLER J L，et al.Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice［J］.PLoS One，2012，7（4）：e35979.
XU L，ZHANG L，WANG Z，et al.Melatonin suppresses estrogen deficiency-induced osteoporosis and promotes osteoblastogenesis by inactivating the NLRP3 inflammasome［J］.Calcif Tissue Int，2018，103（4）：400-410.
WANG L，CHEN K，WAN X，et al.NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation［J］.Biochem Biophys Res Commun，2017，484（4）：871-877.
YIN W，LIU S，DONG M，et al.A new NLRP3 inflammasome inhibitor，dioscin，promotes osteogenesis［J］.Small，2020，16（1）：e1905977.
左远胜，何智圣，付中明，等.防己诺林碱通过Nrf2/NLRP3途径对去卵巢骨质疏松大鼠骨结构和成骨细胞凋亡的影响［J］.实用药物与临床，2021，24（10）：881-886.
LU L，WANG Z，ZHANG H，et al.Drynaria fortunei improves lipid profiles of elderly patients with postmenopausal osteoporosis via regulation of Notch1-NLRP3 inflammasome-mediated inflammation［J］.Gynecol Endocrinol，2022，38（2）：176-180.
GLYN-JONES S，PALMER A J，AGRICOLA R，et al.Osteoarthritis［J］.Lancet，2015，386（9991）：376-387.
HWANG H S，KIM H A.Chondrocyte apoptosis in the pathogenesis of osteoarthritis［J］.Int J Mol Sci，2015，16（11）：26035-26054.
SCANZELLO C R，GOLDRING S R.The role of synovitis in osteoarthritis pathogenesis［J］.Bone，2012，51（2）：249-257.
MCALLISTER M J，CHEMALY M，EAKIN A J，et al.NLRP3 as a potentially novel biomarker for the management of osteoarthritis［J］.Osteoarthritis Cartilage，2018，26（5）：612-619.
CLAVIJO-CORNEJO D，MARTÍNEZ-FLORES K，SILVA-LUNA K，et al.The Overexpression of NALP3 inflammasome in knee osteoarthritis is associated with synovial membrane prolidase and NADPH oxidase 2［J］.Oxid Med Cell Longev，2016，2016：1472567.
CHEN Z，ZHONG H，WEI J，et al.Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis［J］.Arthritis Res Ther，2019，21（1）：300.
SANTANGELO K S，NUOVO G J，BERTONE A L.In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis［J］.Osteoarthritis Cartilage，2012，20（12）：1610-1618.
BONDESON J，WAINWRIGHT S D，LAUDER S，et al.The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases， matrix metalloproteinases， and other destructive and inflammatory responses in osteoarthritis［J］.Arthritis Res Ther，2006，8（6）：R187.
VERMA P，DALAL K.ADAMTS-4 and ADAMTS-5： Key enzymes in osteoarthritis［J］.J Cell Biochem，2011，112（12）：3507-3514.
DAI S M，SHAN Z Z，NISHIOKA K，et al.Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis：Direct effect on chondrocytes may not be pivotal［J］.Ann Rheum Dis，2005，64（5）：735-742.
JOOSTEN L A，SMEETS R L，KOENDERS M I，et al.Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction［J］.Am J Pathol，2004，165（3）：959-967.
INOUE H，HIRAOKA K，HOSHINO T，et al.High levels of serum IL-18 promote cartilage loss through suppression of aggrecan synthesis［J］.Bone，2008，42（6）：1102-1110.
WOJDASIEWICZ P，PONIATOWSKI Ł A，SZUKIEWICZ D.The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis［J］.Mediators Inflamm，2014，2014：561459.
ZU Y，MU Y，LI Q，et al.Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis［J］.J Orthop Surg Res，2019，14（1）：307.
SHAO M，LV D，ZHOU K，et al.Senkyunolide A inhibits the progression of osteoarthritis by inhibiting the NLRP3 signalling pathway［J］.Pharm Biol，2022，60（1）：535-542.
胡锋，胡小军，李建伟，等.三仁汤调控骨关节炎大鼠关节疼痛和软骨损伤机制研究［J］.时珍国医国药，2022，33（6）：1348-1350.
马晓程，赵亚君，毛世刚.祛寒逐风颗粒对骨性关节炎大鼠炎症反应的影响［J］.中国中医骨伤科杂志，2021，29（9）：16-21，26.
李晓辰，邢润麟，张农山，等.“易层”贴敷抑制NLRP3炎症小体激活改善膝骨关节炎的实验研究［J］.时珍国医国药，2020，31（3）：741-745.
喻溢楠，唐成林，郭啸，等.电针对膝骨关节炎大鼠膝关节滑膜组织细胞焦亡的影响［J］.针刺研究，2022，47（6）：471-478.
LIN YJ，ANZAGHE M，SCHULKE S. Update on the pathomechanism， diagnosis， and treatment options for rheumatoid arthritis［J］.Cells，2020，9（4）：880.
GUO C，FU R，WANG S，et al.NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis［J］.Clin Exp Immunol，2018，194（2）：231-243.
ADDOBBATI C，DA CRUZ H ，ADELINO J E，et al.Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients［J］.Inflamm Res，2018，67（3）：255-264.
NASROLLAHZADEH SABET M，NASRABADI N，JALILI Z，et al.Association of three functional polymorphisms in the NLRP3 gene with susceptibility to rheumatoid arthritis in the iranian population［J］.Iran J Immunol，2021，18（3）：249-258.
CHENG L，LIANG X，QIAN L，et al.NLRP3 gene polymorphisms and expression in rheumatoid arthritis［J］.Exp Ther Med，2021，22（4）：1110.
FUSCO R，SIRACUSA R，GENOVESE T，et al.Focus on the role of NLRP3 inflammasome in diseases［J］.Int J Mol Sci，2020，21（12）：4223.
VANDE WALLE L，VAN OPDENBOSCH N，JACQUES P，et al.Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis［J］.Nature，2014，512（7512）：69-73.
SARDAR S，ANDERSSON Å.Old and new therapeutics for rheumatoid arthritis： In vivo models and drug development［J］.Immunopharmacol Immunotoxicol，2016，38（1）：2-13.
GUO C，FU R，WANG S，et al.NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis［J］.Clin Exp Immunol，2018，194（2）：231-243.
MCINNES I B，SCHETT G.Cytokines in the pathogenesis of rheumatoid arthritis［J］.Nat Rev Immunol，2007，7（6）：429-442.
RUSCITTI P，CIPRIANI P，CARUBBI F，et al.The role of IL-1β in the bone loss during rheumatic diseases［J］.Mediators Inflamm，2015，2015：782382.
ZHANG H，WANG S，HUANG Y，et al.Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation［J］.Clin Immunol，2015，157（2）：175-186.
ZHANG W，CONG X L，QIN Y H，et al.IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis［J］.Inflammation，2013，36（1）：103-109.
WEI X Q，LEUNG B P，ARTHUR H M，et al.Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18［J］.J Immunol，2001，166（1）：517-521.
WANG M，LI H，WANG Y，et al.Anti-rheumatic properties of gentiopicroside are associated with suppression of ROS-NF-κB-NLRP3 axis in fibroblast-like synoviocytes and NF-κB pathway in adjuvant-induced arthritis［J］.Front Pharmacol，2020，11：515.
何志明，黄之镨，韦迎春，等.基于NLRP3炎性小体探讨金铁锁提取物对类风湿性关节炎治疗机制的研究［J］.中国中药杂志，2021，46（17）：4504-4510.
LI W，MAO X，WANG X，et al.Disease-modifying anti-rheumatic drug prescription Baihu-Guizhi decoction attenuates rheumatoid arthritis via suppressing Toll-like receptor 4-mediated NLRP3 inflammasome activation［J］.Front Pharmacol，2021，12：743086.
何晓瑾，王磊，孔甜，等.痛痹颗粒对Ⅱ型胶原关节炎小鼠炎性反应及NLRP3炎性小体表达的影响［J］.南京中医药大学学报，2020，36（2）：229-234.
李楠，马庆宇，韩隆胤，等.补肾活血法对类风湿关节炎软骨细胞焦亡及HMGB1/NLRP3信号通路的影响［J］.中华中医药杂志，2022，37（4）：1929-1933.
陈俊，刘华辉，路晓清，等.艾灸对实验性类风湿性关节炎家兔滑膜组织NLRP3炎性小体激活因素Cathepsin-B、ROS水平的影响［J］.中华中医药学刊，2022，40（9）：152-157，278-280.
DEHLIN M，JACOBSSON L，RODDY E.Global epidemiology of gout： Prevalence，incidence， treatment patterns and risk factors［J］.Nat Rev Rheumatol，2020，16（7）：380-390.
SZEKANECZ Z，SZAMOSI S，KOVÁCS G E，et al.The NLRP3 inflammasome-interleukin 1 pathway as a therapeutic target in gout［J］.Arch Biochem Biophys，2019，670：82-93.
SO A K，MARTINON F.Inflammation in gout： Mechanisms and therapeutic targets［J］.Nat Rev Rheumatol，2017，13（11）：639-647.
YANG G，LEE H E，MOON S J，et al.Direct binding to NLRP3 pyrin domain as a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis［J］.Arthritis Rheumatol，2020，72（7）：1192-1202.
LIU W H，SHI L S，CHUNG M C，et al.Antcamphin M inhibits TLR4-mediated inflammatory responses by upregulating the Nrf2/HO-1 pathway and suppressing the NLRP3 inflammasome pathway in macrophages［J］.Am J Chin Med，2019，47（7）：1611-1626.
OUYANG X，LI N Z，GUO M X，et al.Active flavonoids from lagotis brachystachya attenuate monosodium urate-induced gouty arthritis via inhibiting TLR4/MyD88/NF-κB pathway and NLRP3 expression［J］.Front Pharmacol，2021，12：760331.
HE Y，YANG Q，WANG X，et al.Inhibition of triggering receptor expressed on myeloid cell-1 alleviates acute gouty inflammation［J］.Mediators Inflamm，2019，2019：5647074.
ZHANG Q B，QING Y F，HE Y L，et al.Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population［J］.Clin Rheumatol，2018，37（1）：235-244.
WANG L F，DING Y J，ZHAO Q，et al.Investigation on the association between NLRP3 gene polymorphisms and susceptibility to primary gout［J］.Genet Mol Res，2015，14（4）：16410-16414.
LI W Y，YANG F，CHEN J H，et al.β-Caryophyllene ameliorates MSU-induced gouty arthritis and inflammation through inhibiting NLRP3 and NF-κB signal pathway：In silico and in vivo［J］.Front Pharmacol，2021，12：651305.
MARCHETTI C，SWARTZWELTER B，KOENDERS M I，et al.NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis［J］.Arthritis Res Ther，2018，20（1）：169.
元明慧，姜禹辰，廉丽花，等.白芷提取物及其活性成分欧前胡素改善痛风性关节炎［J］.中国药理学通报，2022，38（9）：1416-1420.
金晓敏，张晓熙，郭璐，等.基于NLRP3炎性体轴土茯苓总黄酮对痛风性关节炎的作用和机制［J］.中国实验方剂学杂志，2018，24（4）：90-95.
马天红，盛涛，田崇梅，等.虎杖醇提物通过NLRP3/ASC/Caspase-1轴干预小鼠急性痛风性关节炎的作用研究［J］.中国中药杂志，2019，44（3）：546-552.
ZHANG X，DING H，HU G，et al.Simiaosan alleviates the symptoms of gouty arthritis via the NALP3/IL‑1β pathway［J］.Mol Med Rep，2021，23（3）：223.
房树标，王永辉，李艳彦，等.基于NLRP3炎性体信号通路研究桂枝芍药知母汤治疗痛风性关节炎的作用机制［J］.中国实验方剂学杂志，2016，22（9）：91-95.
范为民.通痹七物方对痛风性关节炎NLRP3炎症小体、线粒体自噬蛋白的影响［J］.中药新药与临床药理，2020，31（7）：769-774.
0
Views
19
下载量
2
CSCD
- H-PDFDownload
- L-PDFDownload
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Publicity Resources
Related Articles
Related Author
Related Institution
- Postal code：100700
- Tel：010-84076882 Email：syfjx_2010@188.com
- Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10
京公网安备11010802024621 - It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
- Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
